|
|
Article: SpectruMedix Awarded SBIR Phase II Grant from the National Heart, Lung And Blood Institute to Develop a "Rapid, Automated Method for MIGET By Mass Spectrometry".
- Article from:
- PR Newswire
- Article date:
- September 14, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
STATE COLLEGE, Pa., Sept. 14 /PRNewswire/ --
SpectruMedix Corporation (OTC Bulletin Board: SMDX) has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute at the National Institutes of Health. The $750,000 grant was awarded to support the development of a "Rapid, Automated Method for MIGET by Mass Spectrometry."
In collaboration with researchers at the University of Pennsylvania, SpectruMedix is developing technology designed to enable the accurate and rapid assessment of pulmonary function, as well as identifying any of a long list of lung diseases and conditions in real time. This ...